Viral Hepatitis Affects Over 300 Million Worldwide; Experts Urge Vaccination and Early Treatment

More than 300 million people globally are living with viral hepatitis, mainly Hepatitis B and C, according to experts who stress the vital role of vaccination, screening, and early treatment. Viral hepatitis, an inflammation of the liver, can lead to life-threatening diseases such as cirrhosis and liver cancer if left untreated.

Dr. Hüsrev Diktaş, an Infectious Diseases and Clinical Microbiology specialist at Medipol Acıbadem Regional Hospital, highlighted that while Hepatitis B can be prevented through vaccination and Hepatitis C is fully treatable with effective drugs, the diseases often progress without noticeable symptoms. He noted that the Hepatitis B vaccine administered to newborns in Turkey has significantly reduced the incidence of the disease, underscoring the importance of immunization for public health.

Diktaş urged for wider implementation of screening tests. "Vaccinating individuals without Hepatitis B immunity and treating patients diagnosed with Hepatitis C without delay prevents disease progression and transmission," he stated. He also pointed out that Hepatitis B and C are transmitted through similar routes, with blood and blood product screening greatly reducing risks. However, transmission from mother to baby, unprotected sexual contact, and unhygienic practices during manicures, pedicures, tattooing, and ear piercing remain significant risks.

He advised choosing reputable centers for such procedures to minimize the risk of infection. The information was shared in conjunction with World Hepatitis Day on July 28, emphasizing the ongoing global health challenge posed by these viral infections.